We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The agency said “there isn’t enough evidence to support the use of stem cells for purposes other than reconstitution of blood formation and the immune system.” Read More
Federal officials on Wednesday filed to intervene in a whistleblower suit alleging that English drugmaker Mallinckrodt used a copay charity as a front for illegal kickbacks. Read More
Attorneys General who have painted the generics industry as an illegal price-fixing cabal should face their state employee health plans and demand they only pay for brand name drugs, the head of the largest generics lobbying group said Wednesday. Read More
Additionally, a reinstatement fee goes into effect on that date for sponsors who have allowed their GMP clearance to lapse beyond the 30-day limit. Read More
The Drug Enforcement Agency on Tuesday urged Congress to classify illicit fentanyl analogues as Schedule I drugs permanently, claiming they’re a significant danger to public health. Read More
The House Appropriations committee on Tuesday approved nearly $3.3 billion in spending for the FDA for fiscal year 2020 and once again nudged the agency to get going on its delayed continuous manufacturing initiative. Read More